Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO)

Evelo Biosciences, Inc. (NASDAQ:EVLO) was the recipient of unusually large options trading on Wednesday. Stock investors acquired 1,885 put options on the stock. This is an increase of 1,101% compared to the typical volume of 157 put options.

Evelo Biosciences Price Performance

Evelo Biosciences stock opened at $0.00 on Thursday. Evelo Biosciences has a one year low of $0.00 and a one year high of $0.07.

About Evelo Biosciences

Evelo Biosciences, Inc, a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.